GGHSX Mutual Fund

GGHSX Mutual Fund

NAV$44.69
See how much of GGHSX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Sep 30, 2026

Net Assets
$41,653.64
Expense Ratio
0.72%
Dividend Yield (Current)
-
Holdings
79
Inception Date
Apr 4, 2017
Fund Family
Invesco (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+12.75%
1 Year+16.79%
3 Year+14.63%
5 Year+4.27%
10 Year+9.61%

Asset Allocation

Stocks: 97.00%
Cash: 1.21%
Other: 1.79%
See how much of GGHSX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co10.58%
JNJJohnson & Johnson - Common6.92%
MRKMerck & Company Inc5.08%
UNHUnitedhealth Group Incorporated5.07%
ABBVAbbvie Inc.4.24%
Top 10 Concentration: 46.78%Report Date: Sep 30, 2026
Download all 79 holdings for GGHSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$9.93
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

GGHSX Mutual Fund Overview

GGHSX Mutual Fund (Invesco Health Care Fund Class R6) is managed by Invesco (US) with $41,653.64 in net assets. GGHSX expense ratio is 0.72%, holding 79 positions across sectors including Health Care, Financials, Real Estate. Inception date: 2017-04-04.

GGHSX performance shows a YTD return of 12.75%. The 1-year return is 16.79% and the 5-year return is 4.27%.

GGHSX top holdings include Eli Lilly & Co (10.6%), Johnson & Johnson - Common (6.9%), Merck & Company Inc (5.1%), Unitedhealth Group Incorporated (5.1%), Abbvie Inc. (4.2%). Go to all GGHSX holdings, GGHSX sectors, or GGHSX dividends.

GGHSX can be compared against other funds. Use GGHSX overlap to find shared positions, or GGHSX vs another fund for a side-by-side view. GGHSX alternatives are available via the screener, along with tax-loss harvesting opportunities.